Cetuximab every-2-weeks versus standard weekly dosing administration schedule - supplementary material
收藏Taylor & Francis Group2024-05-15 更新2026-04-16 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Cetuximab_every-2-weeks_versus_standard_weekly_dosing_administration_schedule_-_supplementary_material/24336334/1
下载链接
链接失效反馈官方服务：
资源简介：
<b>Table S1. </b>Studies evaluating cetuximab Q2W plus irinotecan in <i>KRAS</i>-unselected patients<b>Table S2. </b>Studies evaluating cetuximab Q2W plus irinotecan in patients with (<i>K)RAS</i> wt mCRC<b>Table S3. </b>Studies evaluating cetuximab Q2W plus triplet CT in patients with <i>KRAS</i> wt mCRC<b>Table S4. </b>Studies evaluating cetuximab Q2W and Q1W plus intermittent Nordic FLOX* in patients with <i>KRAS</i> exon 2 wt mCRC<b>Table S5. </b>Comparable safety with Q1W and Q2W dosing<b>Table S6. </b>Grade 3/4 AEs in special categories*<b>Table S7. </b>Studies evaluating cetuximab Q2W as first line for R/M SCCHN<br>
提供机构：
Bokemeyer, Carsten; Ciardiello, Fortunato; Tabernero, Josep; Pinto, Carmine; Guigay, Joel; Yoshino, Takayuki; Yamaguchi, Kensei; Esser, Regina; Pfeiffer, Per; Kasper, Stefan; Zielinski, Christoph; Dubreuil, Olivier
创建时间：
2023-10-18
